115 studies (23 from unattributed sources) on BPC-157 curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
Independent certificate-of-analysis evidence from third-party labs — the data behind the studies. Updated as new COAs are verified. Read the full grey-market analysis →
| Manufacturer | Batches | Avg purity | |
|---|---|---|---|
| Unknown vendor (review) | 34 | 99.27% | View COA → |
| Verified Peptides | 32 | 99.46% | View COA → |
| Peptaris | 32 | 99.33% | View COA → |
| Qing Li Peptide | 32 | 97.1% | View COA → |
| Uther Peptide | 31 | 99.71% | View COA → |
| Simple Peptide | 26 | 99.15% | View COA → |
| Hk Peptides | 23 | 99.64% | View COA → |
| (unknown) | 23 | 99.58% | View COA → |
Recent certificates: #31775 (99.19%) · #56470 (99.22%) · #24273 (99.19%) · #26661 (99.53%) · #27705 (99.53%) · #32148 (99.55%)
Manufacturers with published third-party certificates of analysis for BPC-157. Open a vendor to see every batch we've verified.
This comprehensive review underscores the significant therapeutic potential of BPC-157 for accelerating musculoskeletal tissue repair and improving recovery from a wide range of injuries. The consistent preclinical ef…
This detailed understanding of BPC-157's dual action on nitric oxide and angiogenesis provides a strong mechanistic basis for its observed therapeutic effects in tissue repair and regeneration. The ability to selectiv…
This research highlights the multi-faceted therapeutic potential of BPC 157 in addressing complex ocular conditions, moving beyond single-target therapies. By simultaneously promoting ulcer healing, inhibiting neovasc…
This study provides compelling evidence for BPC 157's potent therapeutic potential in resolving complex and challenging wounds like tracheocutaneous fistulas. The identified mechanism, involving the precise modulation…
This research highlights BPC 157's potential as a therapeutic agent for mitigating cardiovascular complications arising from hormonal imbalances or surgical stress, such as those following adrenalectomy. The ability o…
This research underscores BPC 157's potential as a multifaceted cytoprotective agent that could significantly improve outcomes in patients with arrhythmias, especially when combined with conventional antiarrhythmic th…
This review underscores the significant therapeutic potential of BPC 157 and growth factors for treating a wide array of musculoskeletal injuries, including those at complex tissue junctions that are notoriously diffi…
This research provides compelling evidence for BPC 157's potential as a novel, rapid-acting therapeutic agent for life-threatening electrolyte disturbances, conditions that currently pose significant clinical challeng…
The comprehensive chemical characterization of BPC-157 is crucial for understanding its consistent biological effects and its potential as a powerful therapeutic agent. Its ability to promote healing across diverse ti…
This Phase 2 trial represents a significant step towards clinical validation for BPC 157 in human musculoskeletal injury. If successful, it could offer a novel therapeutic approach to accelerate recovery from acute ha…
The completion of this Phase 1 trial represents a crucial step towards understanding the clinical viability of oral BPC-157. Establishing a clear safety profile and pharmacokinetic data for BPC-157 in humans is paramo…
This review underscores the transformative potential of therapeutic peptides to address unmet needs in orthopaedic medicine. By offering targeted biological interventions, peptides could significantly improve patient …
This comprehensive review underscores the broad therapeutic potential of BPC-157 as a single agent capable of both promoting robust tissue regeneration and providing direct pain relief. Its ability to act on multiple …
Free, no account — handy when you're working with BPC-157.